Massachusetts is New England’s oldest adult-use cannabis market, with retail sales beginning in 2018. The state has no fixed statewide license quota but limits ownership and cultivation capacity. The 2026 reform law raised the retail ownership cap from three to six licenses; non-social-equity businesses are limited to five during the initial 12-month application period. Adult-use cultivation remains capped at three licenses and 100,000 square feet of total canopy per licensee.

Operators must secure Host Community Agreements or municipal waivers and satisfy state licensing and local zoning requirements. A 120-day moratorium on new adult-use cultivation applications began June 16, 2026, with limited exceptions. The 2026 law also removed the medical market’s statutory vertical integration requirement, although standalone medical dispensary licensing remains under development. Fully integrated medical licenses remain limited to three per licensee.

‍

July 2026 | Vireo agreed to acquire Cannabist assets, including Massachusetts operations, in a multistate transaction worth up to $35MM

July 2026 | Devi Holdings signed a binding term sheet to sell Massachusetts and New Mexico assets for $12.5MM combined

July 2026 | Sunstream-backed vehicle acquired Parallel assets, including three NETA dispensaries and a Massachusetts production facility; terms undisclosed

June 2026 | Cresco Labs closed a $50MM corporate revolving credit facility with Needham Bank at 7.99%

August 2025 | In Good Health acquired TILT’s Massachusetts dispensary assets for $1.75MM

April 2025 | Ascend completed its acquisition of Massachusetts cultivation and manufacturing licenses for $2.75MM

April 2024 | Massachusetts-based Nova Farms secured $20MM in senior secured financing from Chicago Atlantic

Smaller operators in the Bay State are facing a challenging environment due to oversupply and downward pricing pressure. These conditions have made it difficult to compete with larger MSOs who are able to achieve higher operational effeciencies. Massachusetts has a three dispensary limit and most of the major MSOs have already reached their maximum retail presence.

Though the state had a slow start to adult-use sales in late 2018, the market is now working its way towards the $2B mark. 2022 finished strong with over $1.76B in sales, 2023 saw growth of 1.8% to 1.8B in sales, and 2024 saw another 2.4% bump to $1.84B in sales. We are expecting similar growth numbers trends to persist in 2025. Keep in mind these revenue figures are growing with the backdrop of prices being slashed by more than 50% since the adult use market's inception, indicating that demand for cannabis is growing quite rapidly.

If you have an opportunity to invest in a Massachusetts operation, you won't regret it. Strong business opportunities remain in cultivation and in select retail locations, including the underserved Boston area.

If you are an SSO, bide your time, reap the annual earnings rewards, and wait until something changes on the regulatory front to allow for a monetization event.

While there is some turbulence being felt resulting from the oversaturation of retail locations, there are also many strong signs in the state. Signs point to state-wide consolidation at some point in the future. Operators should keep a close eye on developments in the state as positive and negative trends continue to play out.

‍